First-of-its-kind, rotation-free single-shot PFA catheter supported by strong safety and efficacy data adds to the groundbreaking Affera family of technologies in Europe Successful completion of first
Medtronic and Abbott Laboratories have steady and reliable businesses. They have increased their payouts for a combined 102 years.
Medtronic is months away from upping its quarterly dividend per share for the 48th consecutive year. The medtech company's outsized demand for the Pulsed Field Ablation and Symplicity hypertension fra
Intuitive Surgical's pure-play robotics focus, rising da Vinci 5 utilization and 85% recurring revenues tilt the risk-reward versus diversified Medtronic.
Dynasty Wealth Management LLC purchased a new position in Medtronic PLC (NYSE: MDT) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The
Florida Trust Wealth Management Co decreased its stake in shares of Medtronic PLC (NYSE: MDT) by 13.1% in the undefined quarter, according to the company in its most recent filing with the Securities
Medtronic is divesting a business that's slowing down its margins. The company entered an important market last year.
Copperleaf Capital LLC bought a new stake in shares of Medtronic PLC (NYSE: MDT) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). Th
Medtronic, IQVIA and GE HealthCare show how medical device leaders are turning analytics, AI and enterprise data platforms into recurring revenue engines.
ANGO, BSX and MDT are showing earnings quality improve as higher-margin products take share, supporting margins and durable growth across MedTech.
Medtronic plc (MDT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off
MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily inje
Vertex and Medtronic could see strong momentum this year, while Pfizer is still facing challenges. Regardless of what happens in 2026, though, Vertex and Medtronic have attractive prospects.
Investors looking for stocks in the Medical - Products sector might want to consider either Medtronic (MDT) or EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks presents investor
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE